IBB241108C144000
- 3.90
- 0.000.00%
iShares Biotechnology ETF Newsroom
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Mettler-Toledo Shares Are Trading Lower. The Company Reported Q3 Financial Results.
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday as Investors Step Back From Frenzied Trading Week
Amgen, AstraZeneca Post Phase 3 Win for Nasal Polyps Therapy
Mettler-Toledo Non-GAAP EPS of $10.21 Beats by $0.20, Revenue of $954.54M Beats by $10.13M
Coherus Stock Rallies 19% on Q3 Earnings, Udenyca Production Update
Nasdaq 100 Extends Record Levels Ahead Of Fed Meeting, Tesla Hits 26-Month Highs, Small Caps Stall: What's Driving Markets Thursday?
BMO Capital Maintains Outperform on Gilead Sciences, Raises Price Target to $102
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of FOMC Meeting Announcement
Gilead Sciences Analyst Ratings
Gilead Sciences Declares $0.77 Dividend
Gilead Sciences in Charts: Revenue From Major Products Rises Y/Y in Q3
Gilead Rises as It Raises 2024 Sales, Non-GAAP EPS Outlook
Gilead Sciences Raises FY24 Product Sales Guidance From $27.10B - $27.50B To $27.80B - $28.10B
Gilead Sciences Non-GAAP EPS of $2.02 Beats by $0.47, Revenue of $7.55B Beats by $550M
SA Asks: How Will the U.S. Election Results Impact Healthcare Stocks?
Peering Into Argenx's Recent Short Interest
Vertex Pharmaceuticals Analyst Ratings
Assessing Regeneron Pharmaceuticals's Performance Against Competitors In Biotechnology Industry
Regeneron Pharmaceuticals Analyst Ratings